| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14740338.2.1.95 |
| P698 | PubMed publication ID | 12904128 |
| P2093 | author name string | David Nolan | |
| Frank Christiansen | |||
| P2860 | cites work | Genetic variations in HLA-B region and hypersensitivity reactions to abacavir | Q28214097 |
| Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey | Q29614468 | ||
| Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous | Q32162834 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial | Q34136715 | ||
| Switching effective antiretroviral therapy: a review. | Q34985833 | ||
| Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study | Q35195035 | ||
| Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile | Q39549464 | ||
| Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir | Q43653507 | ||
| Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction | Q43678570 | ||
| Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients | Q43866031 | ||
| Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy | Q44081426 | ||
| Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients | Q44156456 | ||
| Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia | Q44172291 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | California | Q99 |
| workshop | Q27556165 | ||
| P304 | page(s) | 95-101 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego, California, USA 22-25 September 2002. | |
| P478 | volume | 2 |
Search more.